• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Lipoprotein(a) Gene Polymorphism Increases a Risk Factor for Aortic Valve Calcification.脂蛋白(a)基因多态性增加主动脉瓣钙化的危险因素。
J Cardiovasc Dev Dis. 2019 Aug 26;6(3):31. doi: 10.3390/jcdd6030031.
2
Plasma lipoprotein(a) concentration as an independent predictor of hemodynamic progression of aortic valve stenosis.血浆脂蛋白(a)浓度作为主动脉瓣狭窄血液动力进程的独立预测因子。
Mol Cell Biochem. 2020 Sep;472(1-2):199-207. doi: 10.1007/s11010-020-03797-5. Epub 2020 Jun 23.
3
Lipoprotein(a) and calcific aortic valve disease initiation and progression: a systematic review and meta-analysis.脂蛋白(a)与钙化性主动脉瓣疾病的发生和进展:系统评价和荟萃分析。
Cardiovasc Res. 2023 Jul 6;119(8):1641-1655. doi: 10.1093/cvr/cvad062.
4
Correlations between lipoprotein(a) gene polymorphisms and calcific aortic valve disease and coronary heart disease in Han Chinese.载脂蛋白(a)基因多态性与汉族人钙化性主动脉瓣疾病和冠心病的相关性。
J Int Med Res. 2020 Oct;48(10):300060520965353. doi: 10.1177/0300060520965353.
5
Pathobiology of Lp(a) in calcific aortic valve disease.脂蛋白(a)在钙化性主动脉瓣疾病中的病理生物学。
Expert Rev Cardiovasc Ther. 2017 Oct;15(10):797-807. doi: 10.1080/14779072.2017.1367286. Epub 2017 Aug 24.
6
Calcific Aortic Valve Disease: Molecular Mechanisms and Therapeutic Approaches.钙化性主动脉瓣疾病:分子机制与治疗方法
Eur Cardiol. 2015 Winter;10(2):108-112. doi: 10.15420/ecr.2015.10.2.108.
7
Calcific Aortic Valve Disease-Natural History and Future Therapeutic Strategies.钙化性主动脉瓣疾病——自然病史与未来治疗策略
Front Pharmacol. 2020 May 13;11:685. doi: 10.3389/fphar.2020.00685. eCollection 2020.
8
Lipoprotein(a), a Lethal Player in Calcific Aortic Valve Disease.脂蛋白(a),钙化性主动脉瓣疾病中的致命因素。
Front Cell Dev Biol. 2022 Jan 27;10:812368. doi: 10.3389/fcell.2022.812368. eCollection 2022.
9
Role of lipoprotein (a) and LPA KIV2 repeat polymorphism in bicuspid aortic valve stenosis and calcification: a proof of concept study.载脂蛋白(a)和 LPA KIV2 重复多态性在二叶式主动脉瓣狭窄和钙化中的作用:概念验证研究。
Intern Emerg Med. 2019 Jan;14(1):45-50. doi: 10.1007/s11739-018-1925-8. Epub 2018 Aug 11.
10
Multimodality and molecular imaging of matrix metalloproteinase activation in calcific aortic valve disease.钙化性主动脉瓣疾病中基质金属蛋白酶激活的多模态分子成像
J Nucl Med. 2015 Jun;56(6):933-8. doi: 10.2967/jnumed.114.152355. Epub 2015 Apr 23.

引用本文的文献

1
KCNQ1 Polymorphism in the Context of Ischemic Cardiomyopathy: A Potential Key to Decision-Making for Device Implantation.缺血性心肌病背景下的KCNQ1基因多态性:设备植入决策的潜在关键因素
Clin Cardiol. 2025 May;48(5):e70148. doi: 10.1002/clc.70148.
2
Advances in Pathophysiological Mechanisms of Degenerative Aortic Valve Disease.退行性主动脉瓣疾病的病理生理机制进展
Cardiol Res. 2025 Apr;16(2):86-101. doi: 10.14740/cr2012. Epub 2025 Feb 18.
3
Genetics of Calcific Aortic Stenosis: A Systematic Review.钙化性主动脉瓣狭窄的遗传学:系统综述。
Genes (Basel). 2024 Oct 10;15(10):1309. doi: 10.3390/genes15101309.
4
Causal association between triglycerides and cholesterol-lowering medication with non-rheumatic valve disease: A 2-sample Mendelian randomization study.三酰甘油与非风湿性瓣膜病患者降胆固醇药物之间的因果关系:两样本 Mendelian 随机研究。
Medicine (Baltimore). 2024 Jul 19;103(29):e38971. doi: 10.1097/MD.0000000000038971.
5
Methylation status, mRNA and protein expression of the SMAD4 gene in patients with non-melanocytic skin cancers.非黑素细胞性皮肤癌患者中 SMAD4 基因的甲基化状态、mRNA 和蛋白表达。
Mol Biol Rep. 2023 Sep;50(9):7295-7304. doi: 10.1007/s11033-023-08656-2. Epub 2023 Jul 10.
6
Lipoprotein(a) and calcific aortic valve disease initiation and progression: a systematic review and meta-analysis.脂蛋白(a)与钙化性主动脉瓣疾病的发生和进展:系统评价和荟萃分析。
Cardiovasc Res. 2023 Jul 6;119(8):1641-1655. doi: 10.1093/cvr/cvad062.
7
Exploration and validation of the influence of angiogenesis-related factors in aortic valve calcification.血管生成相关因子在主动脉瓣钙化中作用的探索与验证
Front Cardiovasc Med. 2023 Feb 7;10:1061077. doi: 10.3389/fcvm.2023.1061077. eCollection 2023.
8
Lipoprotein(a), a Lethal Player in Calcific Aortic Valve Disease.脂蛋白(a),钙化性主动脉瓣疾病中的致命因素。
Front Cell Dev Biol. 2022 Jan 27;10:812368. doi: 10.3389/fcell.2022.812368. eCollection 2022.
9
Lipoprotein(a)-The Crossroads of Atherosclerosis, Atherothrombosis and Inflammation.脂蛋白(a)-动脉粥样硬化、动脉血栓形成和炎症的十字路口。
Biomolecules. 2021 Dec 24;12(1):26. doi: 10.3390/biom12010026.
10
Current Evidence and Future Perspectives on Pharmacological Treatment of Calcific Aortic Valve Stenosis.钙化性主动脉瓣狭窄药物治疗的当前证据与未来展望
Int J Mol Sci. 2020 Nov 4;21(21):8263. doi: 10.3390/ijms21218263.

本文引用的文献

1
Reduction of cardiovascular risk in subjects with high lipoprotein (a) levels.降低高脂蛋白(a)水平受试者的心血管风险。
J Thorac Dis. 2017 Aug;9(8):2332-2336. doi: 10.21037/jtd.2017.08.67.
2
Lipoprotein(a): A missing culprit in the management of athero-thrombosis?脂蛋白(a):动脉血栓形成管理中的缺失罪魁祸首?
J Cell Physiol. 2018 Apr;233(4):2966-2981. doi: 10.1002/jcp.26050. Epub 2017 Jul 11.
3
A long-acting PAI-1 inhibitor reduces thrombus formation.一种长效的 PAI-1 抑制剂可减少血栓形成。
Thromb Haemost. 2017 Jun 28;117(7):1338-1347. doi: 10.1160/TH16-11-0891. Epub 2017 Apr 13.
4
LPA Gene, Ethnicity, and Cardiovascular Events.脂蛋白A基因、种族与心血管事件
Circulation. 2017 Jan 17;135(3):251-263. doi: 10.1161/CIRCULATIONAHA.116.024611. Epub 2016 Nov 9.
5
Plasminogen activator inhibitor type 1 in platelets induces thrombogenicity by increasing thrombolysis resistance under shear stress in an in-vitro flow chamber model.血小板中的1型纤溶酶原激活物抑制剂在体外流动腔模型中通过增加剪切应力下的溶栓抵抗来诱导血栓形成。
Thromb Res. 2016 Oct;146:69-75. doi: 10.1016/j.thromres.2016.09.002. Epub 2016 Sep 4.
6
Lipoprotein(a) and oxidized phospholipids in calcific aortic valve stenosis.钙化性主动脉瓣狭窄中的脂蛋白(a)与氧化磷脂
Curr Opin Cardiol. 2016 Jul;31(4):440-50. doi: 10.1097/HCO.0000000000000300.
7
Calcific aortic stenosis.钙化性主动脉瓣狭窄。
Nat Rev Dis Primers. 2016 Mar 3;2:16006. doi: 10.1038/nrdp.2016.6.
8
Lipoprotein(a) Levels Are Associated With Subclinical Calcific Aortic Valve Disease in White and Black Individuals: The Multi-Ethnic Study of Atherosclerosis.脂蛋白(a)水平与白人和黑人的亚临床钙化性主动脉瓣疾病相关:动脉粥样硬化多民族研究
Arterioscler Thromb Vasc Biol. 2016 May;36(5):1003-9. doi: 10.1161/ATVBAHA.115.306683. Epub 2016 Mar 3.
9
Lipoprotein(a) is a risk factor for aortic and mitral valvular stenosis in peripheral arterial disease.脂蛋白(a)是外周动脉疾病主动脉瓣和二尖瓣狭窄的一个危险因素。
Eur Heart J Cardiovasc Imaging. 2016 May;17(5):492-7. doi: 10.1093/ehjci/jev338. Epub 2016 Jan 12.
10
Aortic Stenosis: Changing Disease Concepts.主动脉瓣狭窄:不断变化的疾病概念。
J Cardiovasc Ultrasound. 2015 Jun;23(2):59-69. doi: 10.4250/jcu.2015.23.2.59. Epub 2015 Jun 26.

脂蛋白(a)基因多态性增加主动脉瓣钙化的危险因素。

Lipoprotein(a) Gene Polymorphism Increases a Risk Factor for Aortic Valve Calcification.

作者信息

Ozkan Ugur, Ozcelik Fatih, Yildiz Mustafa, Budak Metin

机构信息

Department of Cardiology, Faculty of Medicine, Trakya University, 22030 Edirne, Turkey.

Department of Cardiology, Edirne Sultan 1. Murat State Hospital, 22030 Edirne, Turkey.

出版信息

J Cardiovasc Dev Dis. 2019 Aug 26;6(3):31. doi: 10.3390/jcdd6030031.

DOI:10.3390/jcdd6030031
PMID:31455005
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6787733/
Abstract

Calcific aortic valve disease (CAVD) is a multifactorial condition. Both environmental andgenetic factors play an important role in its etiology. CAVD exhibits a broad spectrum, varying frommild valve thickening to severe valve calcification and stenosis. Progression of the disease consistsof chronic inflammation, lipoprotein deposition, and active leaflet calcification. It is a process similarto coronary artery disease. In this study, we investigated Lp(a) levels and gene polymorphismsassociated with calcific aortic stenosis from blood samples after echocardiography in the evaluationof 75 patients diagnosed with CAVD and 77 controls. Blood tests were run in our laboratory to ruleout certain risk factors before echocardiography examination. A significant association amongsmoking, elevated LDL level and creatinine, low albumin levels, Lp(a) level, rs10455872, andrs3798220 polymorphisms may be considered genetic risk factors for the development of calcificaortic stenosis.

摘要

钙化性主动脉瓣疾病(CAVD)是一种多因素疾病。环境因素和遗传因素在其病因中均起重要作用。CAVD表现出广泛的范围,从轻度瓣膜增厚到严重的瓣膜钙化和狭窄。疾病进展包括慢性炎症、脂蛋白沉积和瓣叶主动钙化。这是一个与冠状动脉疾病相似的过程。在本研究中,我们在对75例诊断为CAVD的患者和77例对照进行超声心动图检查后,从血液样本中调查了与钙化性主动脉瓣狭窄相关的Lp(a)水平和基因多态性。在超声心动图检查前,我们实验室进行了血液检测以排除某些危险因素。吸烟、低密度脂蛋白水平升高和肌酐、低白蛋白水平、Lp(a)水平、rs10455872和rs3798220多态性之间的显著关联可能被视为钙化性主动脉瓣狭窄发生的遗传危险因素。